Commercial Bancgroup vs Peoples Bancorp
CBK and PEBO side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBK and PEBO compare
Peoples Bancorp is the larger company, worth 3.1 times as much as Commercial Bancgroup ($1.4B against $451M).
On earnings, Commercial Bancgroup is cheaper: it trades at 11.2× trailing earnings, against 11.3× for Peoples Bancorp.
Commercial Bancgroup grew revenue faster over the last twelve months (5.4% versus 2.8% for Peoples Bancorp).
Peoples Bancorp keeps more of each dollar of sales as profit, with a net margin of 136% compared with 42.1% at Commercial Bancgroup.
Both pay dividends: Commercial Bancgroup yields 0.97% and Peoples Bancorp 4.4%.
Peoples Bancorp scores higher on the StockData Score (15 against 10 for Commercial Bancgroup), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBK | PEBO |
|---|---|---|
| Size and price | ||
| Market cap | $451M | $1.4B |
| Share price | $32.94 | $38.37 |
| Change, 1 year | 36.0% | 32.4% |
| Change, 5 years | – | 16.2% |
| Beta (5Y) | 0.40 | 0.57 |
| Employees | 281 | 1,454 |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 0 | 0 |
| Performance score | 3 | 4 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 11.2× (better) | 11.3× |
| P/S | 4.8× (better) | 15.5× |
| P/B | 1.5× | 1.1× (better) |
| EV/EBITDA | – | 11.7× |
| P/FCF | 11.7× | 8.1× (better) |
| FCF yield | 8.5% | 12.4% (better) |
| Fair value | $31.96 | $37.56 |
| Margin of safety | −3.1% | −2.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.4% (better) | 2.8% |
| Revenue growth, 5Y average | – | 10.0% |
| Net income growth (TTM) | 21.4% (better) | 19.0% |
| EPS growth (TTM) | 11.8% | 18.5% (better) |
| EPS growth, 5Y average | – | 11.6% |
| Profitability | ||
| Operating margin | – | 171% |
| Net margin | 42.1% | 136% (better) |
| FCF margin | 41.2% | 192% (better) |
| Return on equity | 15.1% (better) | 10.1% |
| Return on invested capital | – | 7.7% |
| Financial health | ||
| Debt / equity | 0.58 | 0.57 (better) |
| Net debt / EBITDA | – | 2.65 |
| Altman Z-score | 0.33 (better) | 0.23 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.97% | 4.4% (better) |
| Payout ratio | 7.0% | 49.1% |
| Years of dividend growth | 1 | 8 (better) |
| Dividend growth, 5Y average | – | 3.5% |
| Buyback yield | – | −0.06% |
| Shareholder yield | 0.97% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 55.5% | 66.0% |
| Held by insiders | 36.3% | 3.8% |
| Insider net buying, 12 months | $144K (better) | −$431K |
| Short interest, % of float | 1.8% | 8.4% |
Go deeper
- CBK stock overview
- CBK income statement
- CBK valuation and score
- PEBO stock overview
- PEBO income statement
- PEBO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.